University of Alberta
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Prostate Cancer Screening
MRI
ExactVu
PHASE3
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 1284 participants |
Masking : | NONE |
Primary Purpose : | SCREENING |
Official Title : | A Phase 3, Multicenter, International, Non-inferiority, Randomized Clinical Trial Comparing Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging (MUSIC-Screen) |
Actual Study Start Date : | 2024-12-01 |
Estimated Primary Completion Date : | 2029-11-30 |
Estimated Study Completion Date : | 2029-11-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 50 Years to 70 Years |
Sexes Eligible for Study: | MALE |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
University of Alberta
Edmonton, Alberta, Canada, T6G 1Z1